We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

    Purpose

    Guidelines recommend endocrine treatment for estrogen receptor-positive (ER+) breast cancers for up to 10 years. Earlier data suggest that the...

    M. Opdam, V. van der Noort, ... S. C. Linn in Breast Cancer Research and Treatment
    Article Open access 19 May 2022
  2. Nomogram prediction of the 70-gene signature (MammaPrint) binary and quartile categorized risk using medical history, imaging features and clinicopathological data among Chinese breast cancer patients

    Background

    The 70-gene signature (70-GS, MammaPrint) test has been recommended by the main guidelines to evaluate prognosis and chemotherapy benefit...

    Bo Pan, Ying Xu, ... Qiang Sun in Journal of Translational Medicine
    Article Open access 09 November 2023
  3. The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer

    Purpose

    Genomic expression assays provide prognostic information and guide adjuvant chemotherapy decisions for patients with estrogen receptor...

    J. Asher Jenkins, Schelomo Marmor, ... Todd M. Tuttle in Breast Cancer Research and Treatment
    Article 29 October 2021
  4. Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer

    Purpose

    Studies have shown that screen detection by national screening programs is independently associated with better prognosis of breast cancer....

    J. M. N. Lopes Cardozo, M. K. Schmidt, ... C. A. Drukker in Breast Cancer Research and Treatment
    Article 30 June 2021
  5. Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer

    Background

    The Neoadjuvant Breast Symphony Trial (NBRST) demonstrated the 70-gene risk of distant recurrence signature, MammaPrint, and the 80-gene...

    Pat Whitworth, Peter D. Beitsch, ... William Audeh in Annals of Surgical Oncology
    Article Open access 04 April 2022
  6. Bioinformatics analysis of signature genes related to cell death in keratoconus

    Keratoconus is corneal disease in which the progression of conical dilation of cornea leads to reduced visual acuity and even corneal perforation....

    **ghua Liu, Juan Gao, ... Xuan Li in Scientific Reports
    Article Open access 03 June 2024
  7. The spike gene target failure (SGTF) genomic signature is highly accurate for the identification of Alpha and Omicron SARS-CoV-2 variants

    The Alpha (B.1.1.7) and Omicron (B.1.1.529, BA.1, BA.4 and BA.5) variants of concern (VOC) share several mutations in their spike gene, including...

    Tracy McMillen, Krupa Jani, ... N. Esther Babady in Scientific Reports
    Article Open access 08 November 2022
  8. A prognostic neural epigenetic signature in high-grade glioma

    Neural–tumor interactions drive glioma growth as evidenced in preclinical models, but clinical validation is limited. We present an epigenetically...

    Richard Drexler, Robin Khatri, ... Franz L. Ricklefs in Nature Medicine
    Article Open access 17 May 2024
  9. Identification of a Notch transcriptomic signature for breast cancer

    Background

    Dysregulated Notch signalling contributes to breast cancer development and progression, but validated tools to measure the level of Notch...

    Eike-Benjamin Braune, Felix Geist, ... Urban Lendahl in Breast Cancer Research
    Article Open access 03 January 2024
  10. Validation of a methylation-based signature for subventricular zone involvement in glioblastoma

    Purpose

    Glioblastomas (GBM) with subventricular zone (SVZ) contact have previously been associated with a specific epigenetic fingerprint. We aim to...

    Felix Ehret, Oliver ZĂĽhlke, ... David Kaul in Journal of Neuro-Oncology
    Article Open access 20 February 2024
  11. Combining a machine-learning derived 4-lncRNA signature with AFP and TNM stages in predicting early recurrence of hepatocellular carcinoma

    Background

    Near 70% of hepatocellular carcinoma (HCC) recurrence is early recurrence within 2-year post surgery. Long non-coding RNAs (lncRNAs) are...

    Yi Fu, Anfeng Si, ... Hailong Wu in BMC Genomics
    Article Open access 27 February 2023
  12. PTK2-associated gene signature could predict the prognosis of IPF

    Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with a poor prognosis. Current/available clinical prediction tools have...

    Anlin Feng, Yesenia Moreno Caro, ... Ting Wang in Respiratory Research
    Article Open access 06 December 2023
  13. Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL

    Recent genetic and molecular classification of DLBCL has advanced our knowledge of disease biology, yet were not designed to predict early events and...

    Kerstin Wenzl, Matthew E. Stokes, ... Anne J. Novak in Blood Cancer Journal
    Article Open access 20 June 2024
  14. Identification of a cholesterol metabolism-related prognostic signature for multiple myeloma

    Multiple myeloma (MM) is a prevalent hematological malignancy that poses significant challenges for treatment. Dysregulated cholesterol metabolism...

    Na Zhao, Chunxia Qu, ... Zhiguo Long in Scientific Reports
    Article Open access 08 November 2023
  15. Anoikis-related signature predicts prognosis and characterizes immune landscape of ovarian cancer

    Ovarian cancer (OV) is the most lethal gynecological malignancy worldwide, with high recurrence rates. Anoikis, a newly-acknowledged form of...

    Jiani Yang, Yue Zhang, ... Yu Wang in Cancer Cell International
    Article Open access 03 February 2024
  16. A novel pyroptosis-related gene signature exhibits distinct immune cells infiltration landscape in Wilms’ tumor

    Background

    Wilms’ tumor (WT) is the most common renal tumor in childhood. Pyroptosis, a type of inflammation-characterized and immune-related...

    Yujun Guo, Wenjun Lu, ... Zhaozhu Li in BMC Pediatrics
    Article Open access 27 April 2024
  17. Featured lncRNA-based signature for discriminating prognosis and progression of hepatocellular carcinoma

    Long non-coding RNAs (lncRNAs) have been implicated in carcinogenesis and progression of hepatocellular carcinoma (HCC). This study aimed to identify...

    Huiyuan Qiu, Bo Jiang, ... **aolei Cao in Journal of Applied Genetics
    Article 12 February 2024
  18. Identification of an early survival prognostic gene signature for localized osteosarcoma patients

    Osteosarcoma is the most prevalent bone tumor in pediatric patients. Neoadjuvant chemotherapy has improved osteosarcoma patient survival, however the...

    Tajhal D. Patel, Sandra L. Grimm, ... Cristian Coarfa in Scientific Reports
    Article Open access 27 March 2024
  19. Improving arabic signature authentication with quantum inspired evolutionary feature selection

    Offline signature verification (OSV) and identification systems have been used to identify individuals. It has become a significant task to validate...

    Ansam A. Abdulhussien, Mohammad F. Nasrudin, ... Zaid A. Alyasseri in Multimedia Tools and Applications
    Article 08 February 2024
Did you find what you were looking for? Share feedback.